JLJiangguo Lin

Jiangguo Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiangguo Lin has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Aiying Liu

    School of Medicine, South China University of Technology, Guangzhou, People's Republic of China

    1 shared publication
  • Guangzhou Qu

    School of physics, Sun Yat-sen University, Guangzhou, People's Republic of China

    1 shared publication
  • Jiangguo Lin

    Department of Medical Research, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Southern Medical University Guangzhou China

    1 shared publication
  • Jianhua Wu

    School of Biology and Biological Engineering South China University of Technology Guangzhou China

    1 shared publication
  • Jie Ma

    School of physics, Sun Yat-sen University, Guangzhou, People's Republic of China

    1 shared publication
  • Jinhua Fang

    Department of Medical Research, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, People's Republic of China

    1 shared publication

Latest Publications

  • Open Access

    Von Willebrand factor A2 domain inhibits A1-DNA binding while preserving A1-platelet interaction under flow: evidence from recombinant domain constructs

    by Zhitong Peng, Xiaoxi Sun, Guangzhou Qu, Jinhua Fang, Aiying Liu, Yuming Huang, Zhiwei Wu, Junxian Yang, Jie Ma, Jiangguo Lin

  • Aggregation of Platelets and Human EGFR Mutant Lung Adenocarcinoma Cells Under Flow Is Governed by Shear Accumulation

    by Xiaoxi Sun, Xiang Fang, Ying Fang, Jianhua Wu, Jiangguo Lin

    Background: Circulating tumor cells (CTCs) utilize platelets to withstand hemodynamic stress and evade immune clearance; however, the mechanisms driving platelet–cancer cell aggregation under flow remain unclear. Objective: We investigated which physical quantity—shear rate, exposure time, or an integrated metric—governs the aggregation and identified the key adhesion molecules involved. Methods: Human platelets and EGFR‐mutant lung adenocarcinoma PC‐9 cells were fluorescently labeled, mixed at a 10:1 ratio, and subjected to mechanical stimulation using a vortex mixer or a TA ARES G2 rheometer across shear rates 0–4050 s −1 and durations of 0–4860 s. Aggregates were quantified by flow cytometry via dual‐positive gating. The functional roles of platelet P‐selectin and CD40 ligand (CD40L) were assessed using antibodies Inclacumab and 5c8, respectively. Shear significantly promoted platelet–PC‐9 aggregation compared with static conditions, while blocking P‐selectin or CD40L markedly suppressed this effect. Results: Aggregation exhibited a biphasic dependence on both shear rate and exposure time. Notably, when plotting aggregation against shear accumulation (rate × time), all data converged onto a unified biphasic curve with an optimum of ~27 000. Conclusions: These results indicate that platelet–PC‐9 aggregation is governed by a shear accumulation–dependent mechanism, optimized under moderate shear and finite exposure, and regulated by P‐selectin and CD40L. These findings provide new biophysical insights into transient platelet‐PC‐9 interactions in circulation and suggest that targeting platelet activation pathways or modulating hemodynamics may prevent hematogenous metastasis.